A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 755 participants.
Also called NCT01149421
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 755 participants
- Sponsor
- Registry
-
NCT01149421 -
CTRI/2010/091/001444
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Brazil, Canada, Czechia, Denmark, India, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT01149421. Randomized; quadruple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2015-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2189265
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01149421- Content hash
e51e86ee85f94146b07588b45d6c9e57249f2269139e4746b77e695ea0c4c737